Jeffrey Trigilio
2022
In 2022, Jeffrey Trigilio earned a total compensation of $1.9M as Chief Financial Officer at Cullinan Therapeutics, a 28% decrease compared to previous year.
Compensation breakdown
| Bonus | $260,352 |
|---|---|
| Option Awards | $686,250 |
| Salary | $452,000 |
| Stock Awards | $510,000 |
| Other | $15,634 |
| Total | $1,924,236 |
Trigilio received $686.3K in option awards, accounting for 36% of the total pay in 2022.
Trigilio also received $260.4K in bonus, $452K in salary, $510K in stock awards and $15.6K in other compensation.
Rankings
In 2022, Jeffrey Trigilio's compensation ranked 1,816th out of 5,744 executives tracked by ExecPay. In other words, Trigilio earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,816 out of 5,744 | 68th |
Division Manufacturing | 955 out of 3,128 | 70th |
Major group Chemicals And Allied Products | 389 out of 1,416 | 73rd |
Industry group Drugs | 355 out of 1,317 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 88 out of 291 | 70th |
Source: SEC filing on April 21, 2023.
Trigilio's colleagues
We found two more compensation records of executives who worked with Jeffrey Trigilio at Cullinan Therapeutics in 2022.